Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

About the Company

慕宝盛科生物医药(上海)有限公司由专注于医疗健康领域的TOP基金通和毓承(6 Dimensions Capital)投资孵化,成立于2020年6月,注册资本为2500万美元。公司致力于具有革新性的、世界前沿技术抗体偶联药物(ADC)的研发,解决临床上未满足的需求。公司作为研发型药企,以肿瘤免疫学为基础,自主研发具有全新作用机制或新靶点的首创药物(first-in-)或*优药物(best-in-),并推动产品进行全球范围的商业化,***限度地发挥抗肿瘤免疫反应在特定患者群体中的潜力。目前公司在上海张江药谷拥有600平米生物学实验室,建立了抗体偶联药物(ADC)研发平台、肿瘤免疫学研发平台。期待您的加入!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 3,313.5645万(美元)
Legal Representative: 华尔东
Date Established:
Credit Code: 91310115MA1K4JYA9L
Registered Address: 中国(上海)自由贸易试验区环科路999弄17号207室

People who follow this company also follow

Competitors (Similar Companies)

生物科技/生物工程 生物制药 生物科技 抗肿瘤药
“微知卓是一家生物医药技术研发商,主要发展生物医疗器械和细胞治疗等高端生物医药技术的研发与制造,利用干细胞分化技术,为用户提供肝损伤、急慢性肝衰竭等肝脏疾病的救护和康复治疗。”
手套 PVC手套 医用耗材 防护用品
医药 生物医药 抗肿瘤药 肿瘤药物
医药 抗体 生物医药 新药研发
医药 药物研发 生物制药 制药
干细胞 再生医学 细胞治疗 CDMO
医药科技 医药创新 中医药 药物设计
生物科技/生物工程 生物科技
生物科技 生物科技/生物工程
“寡核酸药物研发商”
医药 医药科技 医药工业 基因治疗
医药 放射性药物 研发 核素药物
医药 生物医药 医疗科技 医药科技
医药 生物医药 医疗科技 医药科技

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

家政服务
客服
由百度提供